| Riluzole Zentiva 50 mg film-coated tablets EU/1/12/768/001 |
Riluzole |
Aventis Pharma S.A. |
— |
| Rimmyrah EU/1/23/1779/001-002 |
Ranibizumab |
Qilu Pharma Spain S.L. |
— |
| RINVOQ 15 mg prolonged-release tablets EU/1/19/1404/001-005 |
UPADACITINIB, Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| RINVOQ 30 mg prolonged-release tablets EU/1/19/1404/006-009 |
Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| RINVOQ 45 mg prolonged-release tablets EU/1/19/1404/010-011 |
Upadacitinib Hemihydrate |
AbbVie Deutschland GmbH & Co. KG |
— |
| Risedronate Bluefish Once a Week 35 mg film-coated tablets PA1436/017/001 |
Risedronate sodium hemipentahydrate |
Bluefish Pharmaceuticals AB |
Marketed |
| Ristaben 100 mg film-coated tablets EU/1/10/621/13-18 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV, |
— |
| Ristaben 25 mg film-coated tablets EU/1/10/621/1-6 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV |
— |
| Ristaben 50 mg film-coated tablets EU/1/10/621/7-12 |
Sitagliptin as monohydrate phosphate salt |
Merck Sharp & Dohme BV, |
— |
| Ristfor 50 mg/1000 mg film-coated tablets EU/1/10/620/009-016 |
Metformin Hydrochloride, Sitagliptin phosphate |
Merck Sharp & Dohme BV, |
— |
| Ristfor 50 mg/850 mg film-coated tablets EU/1/10/620/1-8 |
Metformin Hydrochloride, Sitagliptin phosphate |
Merck Sharp & Dohme BV |
— |
| Ritonavir Viatris 100 mg Film-coated tablet EU/1/17/1242/001-003 |
Ritonavir |
Viatris Limited |
— |
| RIULVY 174 mg gastro-resistant hard capsules EU/1/25/1947/001-002 |
Tegomil fumarate |
Neuraxpharm Pharmaceuticals S.L. |
— |
| RIULVY 348 mg gastro-resistant hard capsules EU/1/25/1947/003-005 |
Tegomil fumarate |
Neuraxpharm Pharmaceuticals S.L. |
— |
| Rivaroxaban 10 mg film-coated tablets PA22865/010/001 |
Rivaroxaban |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Rivaroxaban 15 mg film-coated tablets PA22865/010/002 |
Rivaroxaban |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Rivaroxaban 20 mg film-coated tablets PA22865/010/003 |
Rivaroxaban |
Renata Pharmaceuticals (Ireland) Limited |
Not marketed |
| Rivaroxaban Accord 10 mg film-coated tablets EU/1/20/1488/012-023 |
Rivaroxaban |
Accord Healthcare S.L.U. |
— |
| Rivaroxaban Accord 15 mg film-coated tablets EU/1/20/1488/024-038 |
Rivaroxaban |
Accord Healthcare S.L.U. |
— |
| Rivaroxaban Accord 15 mg film-coated tablets Rivaroxaban Accord 20 mg film-coated tablets EU/1/20/1488/039 |
Rivaroxaban, Rivaroxaban |
Accord Healthcare S.L.U. |
— |
| Rivaroxaban Accord 2.5 mg film-coated tablets EU/1/20/1488/001-011 |
Rivaroxaban |
Accord Healthcare S.L.U. |
— |
| Rivaroxaban Accord 20 mg film-coated tablets EU/1/20/1488/040-053 |
Rivaroxaban |
Accord Healthcare S.L.U. |
— |
| Rivaroxaban Azure 10 mg film-coated tablets PA1963/019/002 |
Rivaroxaban |
Cipla Europe |
Not marketed |
| Rivaroxaban Azure 15 mg film-coated tablets PA1963/019/003 |
Rivaroxaban |
Cipla Europe |
Not marketed |
| Rivaroxaban Azure 15 mg film-coated tablets Rivaroxaban Azure 20 mg film-coated tablets PA1963/019/005 |
Rivaroxaban, Rivaroxaban |
Cipla Europe |
Not marketed |
| Rivaroxaban Azure 2.5 mg film-coated tablets PA1963/019/001 |
Rivaroxaban |
Cipla Europe |
Not marketed |
| Rivaroxaban Azure 20 mg film-coated tablets PA1963/019/004 |
Rivaroxaban |
Cipla Europe |
Not marketed |
| Rivaroxaban Bluefish 10 mg film-coated tablets PA1436/044/001 |
Rivaroxaban |
Bluefish Pharmaceuticals AB |
Not marketed |
| Rivaroxaban Bluefish 15 mg film-coated tablets PA1436/044/002 |
Rivaroxaban |
Bluefish Pharmaceuticals AB |
Not marketed |
| Rivaroxaban Bluefish 15 mg film-coated tablets Rivaroxaban Bluefish 20 mg film-coated tablets PA1436/044/004 |
Rivaroxaban, Rivaroxaban |
Bluefish Pharmaceuticals AB |
Not marketed |
| Rivaroxaban Bluefish 20 mg film-coated tablets PA1436/044/003 |
Rivaroxaban |
Bluefish Pharmaceuticals AB |
Not marketed |
| Rivaroxaban MSN 10 mg film-coated tablets PA23250/004/002 |
Rivaroxaban |
MSN Labs Europe Limited |
Not marketed |
| Rivaroxaban MSN 15 mg film-coated tablets PA23250/004/003 |
Rivaroxaban |
MSN Labs Europe Limited |
Not marketed |
| Rivaroxaban MSN 2.5 mg film-coated tablets PA23250/004/001 |
Rivaroxaban |
MSN Labs Europe Limited |
Not marketed |
| Rivaroxaban MSN 20 mg film-coated tablets PA23250/004/004 |
Rivaroxaban |
MSN Labs Europe Limited |
Not marketed |
| Rivaroxaban Rowa 10 mg film-coated tablets PA0074/097/001 |
Rivaroxaban |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Rivaroxaban Rowa 15 mg film-coated tablets PA0074/097/002 |
Rivaroxaban |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Rivaroxaban Rowa 20 mg film-coated tablets PA0074/097/003 |
Rivaroxaban |
Rowa Pharmaceuticals Limited, |
Not marketed |
| Rivaroxaban Viatris 10 mg film-coated tablets EU/1/21/1588/015-025 |
Rivaroxaban |
Viatris Limited |
— |
| Rivaroxaban Viatris 15 mg film-coated tablets EU/1/21/1588/026-040 |
Rivaroxaban |
Viatris Limited |
— |
| Rivaroxaban Viatris 15 mg film-coated tablets Rivaroxaban Viatris 20 mg film-coated tablets EU/1/21/1588/055 |
Rivaroxaban, Rivaroxaban |
Viatris Limited |
— |
| Rivaroxaban Viatris 2.5 mg film-coated tablets EU/1/21/1588/001-014 |
Rivaroxaban |
Viatris Limited |
— |
| Rivaroxaban Viatris 20 mg film-coated tablets EU/1/21/1588/041-054 |
Rivaroxaban |
Viatris Limited |
— |
| Rivastigmine 1 A Pharma 1.5 mg hard capsules EU/1/09/585/001-4 |
Rivastigmine hydrogen tartrate |
1 A Pharma GmbH |
— |
| Rivastigmine 1 A Pharma 2 mg/ml oral solution EU/1/09/585/017-018 |
Rivastigmine hydrogen tartrate |
1 A Pharma GmbH |
— |
| Rivastigmine 1 A Pharma 3 mg hard capsules EU/1/09/585/005-8 |
Rivastigmine hydrogen tartrate |
1 A Pharma GmbH |
— |
| Rivastigmine 1 A Pharma 4.5 mg hard capsules EU/1/09/585/009-12 |
Rivastigmine hydrogen tartrate |
1 A Pharma GmbH |
— |
| Rivastigmine 1 A Pharma 6 mg hard capsules EU/1/09/585/013-16 |
Rivastigmine hydrogen tartrate |
1 A Pharma GmbH |
— |
| Rivastigmine Actavis 1.5 mg hard capsules EU/1/11/693/001-004 |
Rivastigmine hydrogen tartrate |
Actavis Group hf |
— |
| Rivastigmine Actavis 3 mg hard capsules EU/1/11/693/005-008 |
Rivastigmine hydrogen tartrate |
Actavis Group hf |
— |